Results 91 to 100 of about 269 (119)

[Validation of the total morbidity score and investigation of the efficacy of methotrexate in localized scleroderma]. [PDF]

Z Rheumatol
Hoppe AK, Li SC, Foeldvari I.
europepmc   +1 more source

Damage evaluation of craniofacial localized scleroderma using magnetic resonance imaging. [PDF]

Quant Imaging Med Surg
Ma X, Huang J, Xue H, Wang H, Wang T, Chen Y, Long X, Wang X.   +7 more
europepmc   +1 more source

Evaluation of autologous fat grafting in the treatment of juvenile localized scleroderma with facial involvement. [PDF]

J Scleroderma Relat Disord
Sander L, Foeldvari I, Glaser D, Klotsche J, Stier R, Roldán JC.   +5 more
europepmc   +1 more source

Cervical Spine Involvement in Morphea Patients With Subclinical Neurologic Signs. [PDF]

Cureus
Critelli M, Davis T, Flume H, Sarameh Y, Baer CB, Shabbir R, Schwartz JT.   +6 more
europepmc   +1 more source

Juvenile scleroderma [PDF]

, 2016
Wouters, Carine
core  

PP4: Enhancing psychological self-help with implementation intentions for those with a visible skin difference and fear of negative evaluation: a randomised controlled trial [PDF]

, 2017
Lane, J., Thompson, A., Webb, T.
core   +1 more source

An Evaluation of the Performance of Current Morphea Subtype Classifications.

JAMA Dermatol, 2021
Prasad S, Zhu JL, Schollaert-Fitch K, Torok KS, Jacobe HT.   +4 more
europepmc   +1 more source

Het EPIPRE - adviesmodel : beschrijving van modeluitgangspunten en achterliggend onderzoek [PDF]

Drenth, H., Stol, W.
core   +2 more sources

A Report of a Case of Reactivation of Plaque Morphea After Sunlight Exposure and a Literature Review. [PDF]

Cureus
Ivanova Z.
europepmc   +1 more source

Changes in Disease Activity and Damage Over Time in Patients With Morphea.

JAMA Dermatol, 2020
O'Brien JC, Nymeyer H, Green A, Jacobe HT.   +3 more
europepmc   +1 more source